Related Experiment Videos
Lung Cancer Evolution: What's Immunity Got to Do with It?
Luc G T Morris1, Timothy A Chan2
1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunogenomics and Precision Oncology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cancer Cell
|May 16, 2019
Summary
Cancer cells evolve through clonal selection driven by genetic and environmental factors. New research reveals how neoantigens interact with the immune system in non-small-cell lung cancer.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Tumor development involves clonal selection influenced by genetic and microenvironmental factors.
- Understanding these evolutionary dynamics is crucial for effective cancer therapies.
- The role of neoantigens in cancer progression is an active area of research.
Purpose of the Study:
- To investigate the interplay between neoantigens and the immune system.
- To gain insights into tumor evolution in untreated non-small-cell lung cancers.
Main Methods:
- Analysis of genetic and microenvironmental factors driving tumor progression.
- Assessment of neoantigen presentation and immune system response.
Main Results:
- Demonstrated a significant interplay between neoantigens and immune responses in non-small-cell lung cancer.
- Identified key genetic and microenvironmental factors influencing clonal selection.
Conclusions:
- Neoantigen-immune system interactions are critical in the context of non-small-cell lung cancer.
- Further research into these interactions may reveal novel therapeutic strategies.